TNF-α promotes invasive growth through the MET signaling pathway

Molecular Oncology

Volumn 9, Issue 2, 2015, Pages 377-388

  Bigatto, Viola ^a   De Bacco, Francesca ^a   Casanova, Elena ^a   Reato, Gigliola ^a,b   Lanzetti, Letizia ^a,b   Isella, Claudio ^a,b   Sarotto, Ivana ^a   Comoglio, Paolo M ^a,b   Boccaccio, Carla ^a,b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

HGF; Inflammation; Invasion; MET; MET inhibitor; TNF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 5 (2,6 DICHLOROBENZYLSULFONYL) 3 [3,5 DIMETHYL 4 [2 (1 PYRROLIDINYLMETHYL) 1 PYRROLIDINYLCARBONYL] 1H PYRROL 2 YLMETHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; CRIZOTINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; SARACATINIB; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SNAIL; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; HGF PROTEIN, HUMAN; MET PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL SURFACE; COLORECTAL CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PARACRINE SIGNALING; TUMOR CELL LINE; TUMOR INVASION;

GASTROPODA;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-MET; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921376290     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.09.002     Document Type: Article

References (46)

1. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006, 25:409-416.
2. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 2009, 9:361-371.
3. Bates R.C., Mercurio A.M. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell 2003, 14:1790-1800.
4. Bernards R., Weinberg R.A. A progression puzzle. Nature 2002, 418:823.
5. Bertotti A., et al. Inhibition of Src impairs the growth ofmet-addicted gastric tumors. Clin. Cancer Res. 2010, 16:3933-3943.
6. Boccaccio C., Comoglio P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev. Cancer 2006, 6:637-645.
7. Bongartz T., et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006, 295:2275-2285.
8. Chen Q., et al. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth Differ 1996, 7:821-832.
9. Dai J.Y., et al. The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival. J.Cell Biochem. 2009, 107:1222-1236.
10. De Bacco F., et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J.Natl. Cancer Inst. 2011, 103:645-661.
11. Emaduddin M., et al. Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 2008, 105:2358-2362.
12. Erez N., et al. Cancer-Associated fibroblasts are activated in Incipient Neoplasia to Orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17:135-147.
13. Fu L., Medico E. FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data. BMC Bioinformatics 2007, 8:3.
14. Giordano S., et al. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989, 339:155-156.
15. Grivennikov S.I., et al. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
16. Grotegut S., et al. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 2006, 25:3534-3545.
17. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
18. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next Generation. Cell 2011, 144:646-674.
19. Harrison P.M., Farzaneh F. Regulation of HGF/SF gene expression in MRC-5 cells by N-acetylcysteine. Biochem. Biophys. Res. Commun. 2000, 279:108-115.
20. Jeong S.J., et al. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J.Biol. Chem. 2005, 280:10326-10332.
21. Joffre C., et al. A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 2011, 13:827-837.
22. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
23. Kermorgant S., Parker P.J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J.Cell Biol. 2008, 182:855-863.
24. Malik S.T., et al. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur. J. Cancer 1990, 26:1031-1034.
25. Marisa L., et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. Plos Med. 2013, 10:e1001453.
26. Moghul A., et al. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 1994, 9:2045-2052.
27. Montesano R., et al. Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells. J.Cell Sci. 2005, 118:3487-3500.
28. Naldini L., et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 1991, 10:2867-2878.
29. Naldini L., et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 1992, 11:4825-4833.
30. Orosz P., et al. Enhancement of experimental metastasis by tumor necrosis factor. J.Exp. Med. 1993, 177:1391-1398.
31. Pacchiana G., et al. Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody. J.Biol. Chem. 2010, 285:36149-36157.
32. Pennacchietti S., et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361.
33. Peters S., Adjei A.A. MET: a promising anticancer therapeutic target. Nat. Rev. Clin. Oncol. 2012, 9:314-326.
34. Petrelli A., et al. Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity. Proc. Natl. Acad. Sci. USA 2006, 103:5090-5095.
35. Pincheira R., et al. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J.Immunol. 2008, 181:1288-1298.
36. Popivanova B.K., et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J.Clin. Invest. 2008, 118:560-570.
37. Prat M., et al. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer 1991, 49:323-328.
38. R: Development Core Team R: A Language and Environment for Statistical Computing 2004.
39. Sonnenberg E., et al. Expression of the met-receptor and itsligand, HGF-SF during mouse embryogenesis. EXS 1993, 65:381-394.
40. Tamura M., et al. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J.Biol. Chem. 1993, 268:8140-8145.
41. Thiery J.P., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
42. Trusolino L., et al. MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol. 2010, 11:834-848.
43. Vermeulen L., et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12:468-476.
44. Waelchli R., et al. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorg. Med. Chem. Lett. 2006, 16:108-112.
45. Wu Y., et al. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009, 15:416-428.
46. Yao H.P., et al. MSP-RON signalling in cancer: pathogenesis and therapeutic potential. Nat. Rev. Cancer 2013, 13:466-481.